![Kole Roybal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Kole T.
Roybal is the founder of Arsenal Biosciences, Inc., founded in 2019.
Dr. Roybal is the founder of Dispatch Biotherapeutics, Inc., founded in 2022.
Dr. Roybal is also the founder of Moonlight Bio, Inc...
Dr. Roybal is currently an Advisor at Venrock Associates since 2020.
Kole Roybal active positions
| Companies | Position | Start |
|---|---|---|
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Consultant / Advisor | 01/09/2020 |
Dispatch Biotherapeutics, Inc.
 Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Founder | 01/01/2022 |
Former positions of Kole Roybal
| Companies | Position | End |
|---|---|---|
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Arsenal Biosciences, Inc.
Arsenal Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage and programmable cell therapy company focused on solid tumor cell therapies to defeat cancer | Health Technology |
Dispatch Biotherapeutics, Inc.
Dispatch Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies to harness the immune system | Health Technology |
- Stock Market
- Insiders
- Kole Roybal
